News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series
NCPA: More Than 125 Groups Urge Congress to Pass PBM Reform
In a letter to Congress, the National Community Pharmacists Association (NCPA) addressed the need to pass the PBM Reform Act (H.R. 4317) and 2 companion bills: the Protecting Pharmacies in Medicaid Act (S. 927) and the Patients Before Middlemen Act (S. 882).
Community pharmacies are in crisis. Three things need to change
Walgreens’ chief pharmacy officer proposes fixes to a system that broke long ago
AMA backs the PBM Reform Act
“By prioritizing transparency, competitive markets, and enforceable protections for patients this legislation restores integrity to our prescription drug system.
Federal judge will decide whether to block Arkansas’ new pharmacy benefit manager regulations
A federal judge said Wednesday that he will decide “fairly soon” whether to block Arkansas’ first-in-the-nation law regulating pharmacy benefit managers (PBMs).
Judge blocks parts of Iowa's pharmacy benefit manager law. What it means for prescriptions
Iowa lawmakers passed the law, Senate File 383, with the aim of halting further pharmacy closures in Iowa by reining in pharmacy benefit managers, known as PBMs, that operate in the middle between drug manufacturers and insurance providers.
Ex-FTC lawyers form new firm targeting US antitrust enforcement ‘gaps’
Three former U.S. Federal Trade Commission lawyers and a U.S. attorney who resigned in January opened a new plaintiffs law firm on Tuesday focused on unfair competition, price discrimination and other antitrust law violations.
AMA supports PBM reform in annual meeting
In the annual meeting of its House of Delegates, which concluded on June 11, the American Medical Association adopted a resolution opposing PBM spread pricing practices, including supporting state and federal legislation
PBM Legislation in the Reconciliation Bill is Far From Sweeping PBM Reform
Over the past few years, Congress has attempted to pass “federal PBM reform.” Members of Congress have held numerous hearings related to PBMs and introduced numerous bills seeking to regulate PBMs. Despite the rhetoric in Washington about bipartisan support to regulate PBMs, Congress has not been able to pass meaningful PBM reform.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.